Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients
Public ClinicalTrials.gov record NCT00396214. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Double-Blind, Parallel Group Study To Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the study is to evaluate changes in weight short and long term with bifeprunox and quetiapine. Study participation for the subject is 57 weeks.
Study identification
- NCT ID
- NCT00396214
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 83 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2007 (Type not available)
- Primary completion
- Jan 2008 (Actual)
- Completion
- Jan 2008 (Actual)
- Last update posted
- Jun 4, 2008
2007 – 2008
United States locations
- U.S. sites
- 69
- U.S. states
- 24
- U.S. cities
- 55
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 313 | Anaheim | California | — | — |
| Site 333 | Anaheim | California | — | — |
| Site 323 | Cerritos | California | — | — |
| Site 374 | Costa Mesa | California | — | — |
| Site 326 | Culver City | California | — | — |
| Site 300 | Glendale | California | — | — |
| Site 343 | Long Beach | California | — | — |
| Site 356 | Los Angeles | California | — | — |
| Site 367 | Los Angeles | California | — | — |
| Site 322 | Oceanside | California | — | — |
| Site 316 | Pasadena | California | — | — |
| Site 302 | Sacramento | California | — | — |
| Site 315 | San Diego | California | — | — |
| Site 331 | San Diego | California | — | — |
| Site 340 | San Diego | California | — | — |
| Site 311 | Santa Ana | California | — | — |
| Site 336 | Santa Ana | California | — | — |
| Site 344 | Torrance | California | — | — |
| Site 318 | Denver | Colorado | — | — |
| Site 371 | Darien | Connecticut | — | — |
| Site 358 | Hartford | Connecticut | — | — |
| Site 360 | New Britain | Connecticut | — | — |
| Site 317 | Hialeah | Florida | — | — |
| Site 362 | Largo | Florida | — | — |
| Site 327 | Miami | Florida | — | — |
| Site 373 | Miami | Florida | — | — |
| Site 334 | North Miami | Florida | — | — |
| Site 351 | North Miami | Florida | — | — |
| Site 338 | Orange City | Florida | — | — |
| Site 332 | Tampa | Florida | — | — |
| Site 330 | Atlanta | Georgia | — | — |
| Site 308 | Augusta | Georgia | — | — |
| Site 370 | Decatur | Georgia | — | — |
| Site 366 | Smyma | Georgia | — | — |
| Site 337 | Chicago | Illinois | — | — |
| Site 361 | Oakbrook Terrace | Illinois | — | — |
| Site 335 | Indianapolis | Indiana | — | — |
| Site 341 | Lake Charles | Louisiana | — | — |
| Site 304 | Shreveport | Louisiana | — | — |
| Site 301 | Glen Burnie | Maryland | — | — |
| Site 342 | Towson | Maryland | — | — |
| Site 328 | Detroit | Michigan | — | — |
| Site 357 | Minneapolis | Minnesota | — | — |
| Site 309 | St Louis | Missouri | — | — |
| Site 369 | Omaha | Nebraska | — | — |
| Site 320 | Clementon | New Jersey | — | — |
| Site 347 | Clementon | New Jersey | — | — |
| Site 310 | Buffalo | New York | — | — |
| Site 312 | Buffalo | New York | — | — |
| Site 306 | Cedarhurst | New York | — | — |
| Site 321 | New York | New York | — | — |
| Site 353 | New York | New York | — | — |
| Site 372 | New York | New York | — | — |
| Site 324 | Staten Island | New York | — | — |
| Site 329 | Cincinnati | Ohio | — | — |
| Site 345 | Oklahoma City | Oklahoma | — | — |
| Site 368 | Oklahoma City | Oklahoma | — | — |
| Site 354 | Portland | Oregon | — | — |
| Site 314 | Philadelphia | Pennsylvania | — | — |
| Site 346 | Philadelphia | Pennsylvania | — | — |
| Site 348 | Philadelphia | Pennsylvania | — | — |
| Site 350 | Sioux Falls | South Dakota | — | — |
| Site 352 | Memphis | Tennessee | — | — |
| Site 307 | Austin | Texas | — | — |
| Site 303 | Conroe | Texas | — | — |
| Site 305 | Houston | Texas | — | — |
| Site 325 | San Antonio | Texas | — | — |
| Site 319 | Richmond | Virginia | — | — |
| Site 349 | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 82 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00396214, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2008 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00396214 live on ClinicalTrials.gov.